Evaluation of a Colorectal Cancer Education Training Program

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This clinical trial evaluates the effectiveness of trained community engagement specialists for improving communication on colorectal cancer (CRC) prevention and genetic testing among Hispanic/Latino/a/x (H/L) communities. CRC is the second and third leading cause of cancer deaths among United States (US) H/L men and women respectively. Knowledge of inherited germline mutations (changes in a gene that occurs in a sperm or egg cell) is critical for understanding cause of disease and can impact patient treatment options and outcomes. Educational programs and participant engagement approaches focused on H/L individuals considering Latino cultural values, literacy, numeracy, barriers faced, cultural beliefs and attitudes, as well as language of participants are much needed to address these observed disparities. The Community Genetic Navigation Specialists (CoGENES) Program focuses on increasing knowledge, and preparing the CoGENES trainees to help respond to questions, fears, and concerns regarding genetic testing, counseling, biospecimen (sample of urine, blood, or tissue cells) donation and participation in clinical trials to H/L community members, patients and their families. CoGENES may improve communication on colorectal cancer prevention and genetic testing which can help reduce cancer disparities among H/L communities.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Must be 18 years of age or older

• Ability to understand and the willingness to sign a written informed consent

• Self-reported H/L ethnicity, of any race

• Ability to read, write, and speak Spanish or English

• Resides in Los Angeles County

Locations
United States
California
USC / Norris Comprehensive Cancer Center
RECRUITING
Los Angeles
Contact Information
Primary
Bianca Rosales
Biancar@usc.edu
323-865-0811
Time Frame
Start Date: 2024-06-20
Estimated Completion Date: 2027-06-20
Participants
Target number of participants: 140
Treatments
Active_comparator: Group 1 (usual care)
Participants receive a packet of existing information materials about colorectal cancer prevention, screening, and genetic testing to review at their own pace over 6-10 weeks. Participants may optionally receive a CoGENES training session within 2 weeks post-intervention.
Experimental: Group 2 (CoGENES)
Participants receive a CoGENES training session over 45-60 minutes.
Sponsors
Leads: University of Southern California
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov